Developing medical countermeasures for exposure to hazardous chemicals
Official title: Wake Forest University Vesicant Exposure Resource and Coordination Core
Funded at Wake Forest University Health Sciences · NIH-10937787 · Data updated 2026-11-12
This study is working on finding better treatments and protective measures for people who have been exposed to harmful chemicals, using advanced models to understand how these chemicals affect the body.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project start | September 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $1,070,788 |
| NIH project number | 1U2CEY036984-01 |
| Project ID | NIH-10937787 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who have been exposed to hazardous chemicals or are at risk of such exposure.
✕Less likely to help
Patients who have not been exposed to hazardous chemicals or do not have related health concerns may not benefit from this research.
What this research studies
This research focuses on creating effective medical countermeasures for individuals exposed to highly toxic chemicals. It aims to establish a resource and coordination core that provides advanced experimental models and analytical methods to support the development of these countermeasures. The project will utilize a variety of preclinical models, including studies on corneal, dermal, and pulmonary injuries, to better understand the effects of these hazardous substances. Patients may benefit from improved treatments and protective measures against chemical exposures.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments that protect patients from the harmful effects of chemical exposures.
How similar studies have gone: Other research has shown success in developing medical countermeasures for chemical exposures, indicating that this approach has potential for meaningful advancements.
Where this research is happening
-
Wake Forest University Health Sciences
Winston-Salem, United States Active
Researchers
- Principal investigator: Mcnutt, Patrick Michael — Wake Forest University Health Sciences
- Study coordinator: Mcnutt, Patrick Michael
Related research
Other NIH-funded projects on the same topics.
-
Evaluating a combined approach to manage chronic pain
This study is looking at whether taking duloxetine along with online therapy can help people with chronic pain feel better, and it includes some support to help you stick with the therapy; you'll be randomly placed in one of three groups to see which approach works best over six months.
-
Drd3 gene variants and cocaine seeking in rats
A study in rats will map different Drd3 gene variants to how cocaine-seeking and taking behavior is influenced, aiming to uncover targets for treating cocaine use disorder.
-
Intensive dental care during cancer follow-up to protect teeth after head and neck radiation
A program delivered in oncology clinics to provide fluoride varnish and dental follow-up aims to reduce tooth decay and improve oral health and quality of life for head and neck cancer patients after radiation therapy.
-
Wake Forest NCORP Cancer Center Research Base
A patient-focused opportunity to advance real-world cancer care through community-based studies that address how cancer and its treatments affect daily life and well-being.
-
Hybrid approach to peer-supported mood and incentive program to reduce HIV risk among women who inject drugs
A pilot program tests a combined peer-supported mood-boosting approach with contingency management to help stimulant-using women who inject drugs reduce HIV risk.
-
Coordinating Center for the MoTrPAC project
A large nationwide effort seeks to map how physical activity changes the body at the molecular level, with a coordinating center that handles data, biospecimens, and collaboration across sites.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.